These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 25855444)

  • 1. International sanctions: Sanctions in Iran disrupt cancer care.
    Shahabi S
    Nature; 2015 Apr; 520(7546):157. PubMed ID: 25855444
    [No Abstract]   [Full Text] [Related]  

  • 2. The impact of international economic sanctions on Iranian cancer healthcare.
    Shahabi S; Fazlalizadeh H; Stedman J; Chuang L; Shariftabrizi A; Ram R
    Health Policy; 2015 Oct; 119(10):1309-18. PubMed ID: 26344426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sanctions: Interim initiative for health in Iran.
    Velayati AA; Jamaati H; Hashemian SM
    Nature; 2015 May; 521(7550):32. PubMed ID: 25951274
    [No Abstract]   [Full Text] [Related]  

  • 4. Differences in availability of cancer drugs across Europe.
    Mayor S
    Lancet Oncol; 2016 Sep; 17(9):1196. PubMed ID: 27476616
    [No Abstract]   [Full Text] [Related]  

  • 5. Cancer drug shortages lead to higher costs, greater risk.
    Printz C
    Cancer; 2013 Aug; 119(15):2667. PubMed ID: 23868455
    [No Abstract]   [Full Text] [Related]  

  • 6. Task force hopes to deliver affordable cancer drugs to developing countries.
    Kmietowicz Z
    BMJ; 2009 Nov; 339():b4506. PubMed ID: 19889737
    [No Abstract]   [Full Text] [Related]  

  • 7. Report highlights European inequalities in access to cancer drugs.
    Eur J Cancer; 2005 Dec; 41(18):2779. PubMed ID: 16408332
    [No Abstract]   [Full Text] [Related]  

  • 8. The silent victims of the US embargo against Iran.
    Ghalibafian M; Hemmati S; Bouffet E
    Lancet Oncol; 2018 Nov; 19(11):e580. PubMed ID: 30507483
    [No Abstract]   [Full Text] [Related]  

  • 9. Cancer drugs dropped from 'unsustainable' fund list.
    Nurs Stand; 2015 Sep; 30(4):10. PubMed ID: 26394942
    [No Abstract]   [Full Text] [Related]  

  • 10. Top-up insurance for cancer drugs.
    Sikora K
    Br J Hosp Med (Lond); 2007 Jun; 68(6):288-9. PubMed ID: 17639822
    [No Abstract]   [Full Text] [Related]  

  • 11. Having "Skin in the Game" and Allowing Cross-Border Importation of Drugs to Lower High Prices of Cancer Drugs.
    Kantarjian H; Mathisen MS; Lipton JH
    JAMA Oncol; 2015 Sep; 1(6):729-30. PubMed ID: 26182331
    [No Abstract]   [Full Text] [Related]  

  • 12. Targeted immunotherapies overtaking emerging oncology market value based growth.
    Jakovljevic MB
    J BUON; 2015; 20(1):350-1. PubMed ID: 25778340
    [No Abstract]   [Full Text] [Related]  

  • 13. Health policy: Putting a price on cancer.
    Sullivan R; Aggarwal A
    Nat Rev Clin Oncol; 2016 Mar; 13(3):137-8. PubMed ID: 26856742
    [No Abstract]   [Full Text] [Related]  

  • 14. Many cancer deaths could be eliminated by greater awareness and access to latest treatments, report says.
    Hawkes N
    BMJ; 2015 Jan; 350():h223. PubMed ID: 25589377
    [No Abstract]   [Full Text] [Related]  

  • 15. Placing bets on biotech.
    Weintraub K
    Cancer Discov; 2011 Nov; 1(6):462. PubMed ID: 22586641
    [No Abstract]   [Full Text] [Related]  

  • 16. Will we ever be able to afford good cancer care?
    Sikora K
    Trans Med Soc Lond; 2010-2011; 127():17-21. PubMed ID: 24941635
    [No Abstract]   [Full Text] [Related]  

  • 17. [Cost-effectiveness of cancer drug treatments].
    Akazawa M
    Nihon Rinsho; 2015 Feb; 73 Suppl 2():706-12. PubMed ID: 25831852
    [No Abstract]   [Full Text] [Related]  

  • 18. Eliminate cost-plus reimbursement for drugs.
    Conti RM
    Clin Adv Hematol Oncol; 2014 Jan; 12(1):66. PubMed ID: 25129910
    [No Abstract]   [Full Text] [Related]  

  • 19. Arguing (About) the Value of Cancer Care.
    Abraham I; McBride A; MacDonald K
    J Natl Compr Canc Netw; 2016 Nov; 14(11):1487-1489. PubMed ID: 27799516
    [No Abstract]   [Full Text] [Related]  

  • 20. Why Finland is top of the Euro cancer league.
    Kellokumpu-Lehtinen PL
    Eur J Cancer; 2007 May; 43(8):1229. PubMed ID: 17632890
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.